AI assistant
Sending…
RIGEL PHARMACEUTICALS INC — Director's Dealing 2026
Feb 4, 2026
32801_dirs_2026-02-04_ff3373c2-bb1c-4969-bec5-819097cff116.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2026-02-02
Reporting Person: Schorno Dean L (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-02 | Common Stock | F | 5488 | $36.01 | Disposed | 59247 | Direct |
Footnotes
F1: Includes 500 shares acquired under the Issuer's stock purchase plan.
More from RIGEL PHARMACEUTICALS INC
Regulatory Filings
2026
May 20
Proxy Solicitation & Information Statement
2026
Apr 3
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 3
Annual Report
2026
Mar 3
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19